BSEAuro Laboratories LtdMediumPositive
Announced Tue, 5 May · 19:10 IST

Auro Laboratories Limited submits that the Company has received a ''Certificate of GMP Compliance of a Manufacturer'' from Swissmedic Swiss Agency for Therapeutic Products for the Company''s ....

Regulatory Product ApprovalBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.7%1-day move
₹249.75
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+5.7+8.1+4.1+7.2+8.0+7.3+8.1+1.3+0.7
Up moveDown movePending
AI summary

Auro Laboratories has received a Certificate of GMP Compliance from Swissmedic, Switzerland's regulatory agency for therapeutic products. The certificate (No. 26-0002) covers the company's manufacturing facility at M.I.D.C. Tarapur, Maharashtra, confirming compliance with GMP requirements under the EU-Switzerland Mutual Recognition Agreement. This certification is valid and was issued on May 5, 2026. The company disclosed this under SEBI Listing Regulations. This regulatory approval enables the company to supply pharmaceutical products to markets covered under the EU-Switzerland mutual recognition framework.

Likely market impact

Positive for shareholders as this GMP certification opens doors to regulated international markets including Switzerland and the EU, potentially supporting future export revenue growth.